Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wang Xue

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Oncogene|August 4, 2025
TLL1 knockdown attenuates prostate cancer progression by enhancing antitumor immunityJing-Lan Hao, Jia-Qi He, Hang Hu, et al.
Journal of the National Cancer Center|July 22, 2024
Consensus on clinical diagnosis and medical treatment of HER2-low breast cancer (2022 edition)Bu Hong, Fan Ying, Fan Zhaoqing, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Oncogene|August 4, 2025
TLL1 knockdown attenuates prostate cancer progression by enhancing antitumor immunityJing-Lan Hao, Jia-Qi He, Hang Hu, et al.
Journal of the National Cancer Center|July 22, 2024
Consensus on clinical diagnosis and medical treatment of HER2-low breast cancer (2022 edition)Bu Hong, Fan Ying, Fan Zhaoqing, et al.
Pageof 8